Martin D. Madaus
Interim President and CEO, Azenta, Inc. · United States
Martin D. Madaus is the CEO of Azenta, Inc. (AZTA). Madaus is based in the United States.
Dr. Martin Madaus is an experienced healthcare executive with over 30 years in diagnostics and life science tools. He previously served as Chairman and CEO of Millipore Corporation and Ortho-Clinical Diagnostics, and currently serves as a Senior Operating Executive at the Carlyle Group. He holds a Doctor of Veterinary Medicine and Ph.D. from German universities.
Recent developments
AI summary of recent coverageRecent coverage has focused on Martin D. Madaus's expanded leadership roles across two companies. Madaus was named interim CEO of Azenta in August 2026 following the departure of the previous chief executive, while also being elected chair of Repligen Corporation in January 2026 as successor to retiring chair Tony Hunt.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Martin D. Madaus, it will appear here — and tie into the news timeline.
Martin D. Madaus: FAQ
- Who is Martin D. Madaus?
- Martin D. Madaus is the Interim President and CEO of Azenta, Inc., based in United States.
- What company does Martin D. Madaus lead?
- Martin D. Madaus is CEO of Azenta, Inc..